Join an industry expert in this webinar for key insights on stability testing to support various stages of development and regulatory filings (IND, NDA and ANDA). Register here.
Global wearable device traffic is expected to surpass 40 zettabytes by 2020...one zettabyte equals 1 trillion gigabytes. And this big data explosion is just as apparent within clinical trials.
Learn how data-driven decision-making solutions based on evolving technology are influencing strategies for managing risk, quality and performance management. Register now.
Companies rely on data about healthcare professionals (HCPs), healthcare organizations (HCOs), and their affiliations to manage customer engagement and ensure compliance.
The 2018 US Customer Reference Data Survey examines the current state of customer reference data in life sciences through the opinions and experiences of industry executives across the United States. Respondents will be entered for a chance to win one of 3 $50 Amazon gift cards. Take the survey now!
The development of New Chemical and Biological Entities is becoming more and more challenging.
Join Dr. Lorna Speid and Dr. John Burke for this webinar as they discuss:
- how to develop a Regulatory Strategy
- case studies on how Model-Aided Drug Invention can support regulatory strategy
- and more
When it comes to the conduct of pediatric clinical trials, there are a number of things you need to consider in order to ensure the successful conduct of a study. From study design to logistics to recruitment, this webinar will look at the key differences between studies conducted in pediatric populations and studies conducted in adult populations. Register now.
Discover how increasingly sophisticated technology with advanced analytics is helping clinical investigators and trial leaders overcome certain challenges, and learn how a data-driven approach is a catalyst for optimal study design, improved site selection, and more. Register now!
Looking to clarify and simplify your CCI approval? Although CCI is a very complex issue, the right approach can simplify it. This webinar will provide six key areas to consider in view of Chapter <1207> that enable a holistic approach to optimize sterile product package CCI, and a comprehensive approach to optimizing CCI, including an understanding of the impact of materials, equipment, process, measurement, and more. Register now!
Is Your Life Science Data “F-A-I-R”? Join DataFrameworks & Dell EMC in this webinar to discover a new approach to create scientific data that is findable, accessible, interoperable, and reusable. Register now!
Biopharma and medical device companies can now collaborate on, manage and distribute regulated clinical, lab and manufacturing content in Box. That means all of your content is standardized on a single content repository that meets regulatory and compliance standards, so you can eliminate inefficient silos, enable seamless collaboration and accelerate the validation process. Combining Box with the power of USDM’s Cloud Assurance (Continual Validation), you will never need to worry about validation again. Read more.
- Employee stock option trading & administration
- Restricted stock transactions (Rule 144)
- Affiliated trading plans (10b5-1)
- Directed share plans (friends & family list)
- Equity comp plan administration — private to public
Guiding corporate executives through regulatory complexities, while delivering an array of sophisticated investment options. Learn more.
Atrium Innovations, an innovative leader in the development, manufacturing, and commercialization of science-based nutritional health products, is leveraging cloud technology to bring together 13 sites around the world and multiple functional groups. Register Now to learn more about cloud technology.
By taking advantage of modern screening technologies, drug developers can bridge the gap between molecule discovery and dose form selection with Parallel Screening. This executive summary delves into how this method is the most efficient way of maximizing a NCE’s chances of making it to Phase 1. Download it now!
Join Cardinal Health Specialty Solutions as we review the biosimilar landscape and identify key strategies for overcoming regulatory barriers and getting your biosimilar to market quickly.
In 2018 healthcare leaders will be adjusting their strategies to focus on investments, collaborations and efficiencies that build enterprise resilience on a baseline of continued uncertainty. Discover the risks and uncertainties are moving to center stage next year. Register now!
Hear expert analysis of the 2017 eClinical Landscape Survey, one of the largest, most in-depth surveys of clinical data management professionals that shows the impact of database build delays on trial timelines, as well as the projected increase of data source usage. Register Now.
Getting a new product from the bench into the clinic is a complex endeavor. This webinar will provide an overview of the clinical, nonclinical, CMC, and regulatory activities necessary for a successful IND submission. Register Now.
Download Patheon’s whitepaper to discover two main areas where a drug developer can face significant obstacles during biologics development and how by evaluating these capabilities, it can answer the critical question of whether its in-house strategy is ready for these uncertainties.